bpc-157 evidence human clinical trials safety review Peptide Therapy for Pain Management and Healing bpc-157 human clinical trials bpc-157 human clinical trials safety

Temporary headache or dizziness (reported with limited human use) Safety Considerations None of the significant toxicity indicators were reported in the preclinical tests

The FDA has not approved BPC-157 for any human use

Clinical Update 1/22/2012 Vitamin D and Inflammation A new study found that raising low levels of vitamin D appears to reduce inflammation in the body (based on measurements of C-reactive protein, or CRP, a marker of inflammation)

The lyophilized formulation supports long-term laboratory storage while providing flexibility for experimental preparation

Zinc: Essential for tissue repair and protein synthesis